AQR Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,635
Closed -$3.27M 2342
2022
Q3
$3.27M Buy
21,635
+2,898
+15% +$438K 0.01% 989
2022
Q2
$2.73M Sell
18,737
-2,344
-11% -$342K 0.01% 986
2022
Q1
$2.5M Sell
21,081
-2,407
-10% -$285K ﹤0.01% 1072
2021
Q4
$3.24M Sell
23,488
-5,195
-18% -$716K 0.01% 947
2021
Q3
$3.98M Buy
28,683
+20,713
+260% +$2.88M 0.01% 870
2021
Q2
$774K Sell
7,970
-12,057
-60% -$1.17M ﹤0.01% 1693
2021
Q1
$1.37M Sell
20,027
-190
-0.9% -$13K ﹤0.01% 1408
2020
Q4
$1.73M Sell
20,217
-5,270
-21% -$452K ﹤0.01% 1233
2020
Q3
$1.66M Buy
25,487
+13,802
+118% +$897K ﹤0.01% 1192
2020
Q2
$854K Sell
11,685
-14,685
-56% -$1.07M ﹤0.01% 1518
2020
Q1
$897K Buy
+26,370
New +$897K ﹤0.01% 1381
2018
Q4
Sell
-5,815
Closed -$218K 2392
2018
Q3
$218K Buy
+5,815
New +$218K ﹤0.01% 2178